Introduction {#section5-1179547619871907}
============

Non-syndromic sensorineural hearing loss is the most common sensorineural disorder accounting for \~70% of hereditary hearing loss of which 80% have an autosomal recessive mode of inheritance (autosomal recessive non-syndromic hearing loss \[ARNSHL\]).^[@bibr1-1179547619871907]^ To date, more than 60 genes and more than 100 genetic loci have been identified in patients affected with ARNSHL (Hereditary Hearing Loss Homepage, <http://hereditaryhearingloss.org>). The genes *GJB2, SLC26A4, MYO15A, OTOF*, and *CDH23* are most commonly implicated in ARNSHL.^[@bibr2-1179547619871907]^

The *MYO15A* mutations (NM_016239) have been reported to cause sensorineural hearing loss in human (autosomal recessive 3 \[DFNB3\]).^[@bibr3-1179547619871907]^ The DFNB3 locus (OMIM-600316) was first identified in an isolated village in Indonesia where 2% of their population was affected by hearing loss. Then, the causative role for *MYO15A* gene mutation was identified in DFNB3.^[@bibr4-1179547619871907]^ The *MYO15A* has 66 exons spanning 71 kb of DNA on chromosome 17p11.2.^[@bibr5-1179547619871907]^

The *MYO15A* mRNA transcript encodes a 3530 amino-acid protein (myosin XVa), which has MyTH4 (Myosin Tail Homology 4), SH3 (Src Homology 3), and PDZ domains, and FERM (4.1 protein, Ezrin, Radixin, and Moesin) motifs. Myosin XVa is a critical protein for tip localization of whirlin and differential elongation of hair-cell stereocilia and organization of actin within the hair cells of the cochlea, so myosin XVa is an important element in the normal auditory function.^[@bibr6-1179547619871907]^

There are several linkage analysis studies on mutations of *MYO15A* causing ARNSHL in consanguineous families from Pakistan, Turkey, and Iran.^[@bibr7-1179547619871907][@bibr8-1179547619871907]-[@bibr9-1179547619871907]^ Mutations of *MYO15A* at the DFNB3 locus are the second most common cause of autosomal recessive non-syndromic deafness in Iranian population.^[@bibr7-1179547619871907]^,^[@bibr9-1179547619871907]^ In the present study, we report a novel *MYO15A* mutation identified by clinical exome sequencing in a consanguineous Iranian family with ARNSHL. To the best of our knowledge, this mutation has not been reported in any database.

Materials and Methods {#section6-1179547619871907}
=====================

A 22-year-old woman with hearing loss was referred to the Medical Genetic Department, Urmia University of Medical Sciences, for detection of any possible hereditary hearing loss mutation. Her parents were consanguineous with F = 1/16 (first cousin) ([Figure 1A](#fig1-1179547619871907){ref-type="fig"}), and clinical examination of the patient excludes dysmorphic features. Audiometric records were compatible with sensorineural hearing loss, so the non-syndromic sensorineural hearing loss was postulated.

![(A) The pedigree of the studied family. (B) Confirmation of novel pathogenic variant, c.9611_9612+8delTGGTGAGCAT (p.Leu3204Cysfs\*17), in the *MYO15A* gene by Sanger sequencing.\
The causative mutation was confirmed by capillary sequencing of DNA from the proband and her parents. The affected proband (IV:1) is homozygote for c.9611_9612+8delTGGTGAGCAT (p.Leu3204Cysfs\*17) variant and parents (III:1, III:2) are heterozygote for c.9611_9612+8delTGGTGAGCAT (p.Leu3204Cysfs\*17) variant in the *MYO15A* gene (NM_016239.4).](10.1177_1179547619871907-fig1){#fig1-1179547619871907}

Molecular analysis was performed after obtaining informed consent. Sanger sequencing of *GJB2* and *GJB6* genes which are the most common causes of ARNSHL was negative. Then, clinical exome sequencing was performed on a single proband case. Exome sequencing data were mapped to the human reference (National Center for Biotechnology Information \[NCBI\] build 37.1, UCSC hg19) using Burrows-Wheeler aligner (BWA-MEM, version 0.7.10). All variants were annotated by ANNOVAR and Variant Effect Predictor (VEP). Variants with a read depth \> 20 and Minor allele frequency (MAF) \< 0.01 in the 1000 Genome Project, dbSNP, Exome Aggregation Consortium (ExAC), and ESP-6500 were extracted for further analysis. Finally, the candidate variants were checked in the Human Gene Mutation Database (HGMD), Varsome, and Clinvar.

After preliminary detection of mutation by clinical exome sequencing, polymerase chain reaction (PCR) amplification and Sanger sequencing of the identified mutation was performed for verification of the co-segregation in the studied family. In addition, the detected mutation was searched in the healthy controls database for the same ethnic group (Iranome; <http://www.iranome.ir/>).

Results {#section7-1179547619871907}
=======

A novel homozygous mutation c.9611_9612+8delTGGTGAGCAT (p.Leu3204Cysfs\*17) was found in exon 58 of *MYO15A* in a consanguineous Iranian family with a case of non-syndromic sensorineural hearing loss ([Figure 1B](#fig1-1179547619871907){ref-type="fig"}). This mutation creates a shift in the reading frame starting at codon 3204. The new reading frame ends in a stop codon at position 16 downstream. The deletion is near the highly conserved donor splice site of exon 58. Sanger sequencing confirmed the homozygosity of this mutation in the patient and its heterozygosity in her parents. This variant is classified as likely pathogenic (class 2) according to the recommendations of ACMG (American College of Medical Genetics and Genomics). Using the 1000 Genomes Project database and the ExAC browser, candidate variant was defined as splice-site and frame-shift mutation. The c.9611_9612+8delTGGTGAGCAT (p.Leu3204Cysfs\*17) was not found in healthy controls database for the same ethnic group (Iranome; <http://www.iranome.ir/>). This novel mutation is predicted to disrupt the function of the myosin XVa protein, which is integral to the mechanosensory and neurosensory activity of the hair cells in the inner ear.

The alignment of the *MYO15A* gene from different species of human, chimpanzee, and monkey was analyzed. The result proved that this region was conservative among multiple species which is highly suggesting that these residues are important for the proper protein function.

Discussion {#section8-1179547619871907}
==========

New sequencing technologies like clinical exome sequencing are rapidly becoming a common molecular diagnostic test for individuals with rare and heterogeneous genetic disorders. In this study, a novel mutation was identified by clinical exome sequencing within an Iranian patient with ARNSHL. Hearing loss is a highly heterogeneous disorder and the genetic causes of this disorder have been studied in Iranian populations.^[@bibr10-1179547619871907]^,^[@bibr11-1179547619871907]^ The *MYO15A* mutations affect approximately 5.71% of Iranian^[@bibr12-1179547619871907]^ and 9.9% of Turkish ARNSHL patients.^[@bibr13-1179547619871907]^

Pathogenic variants in the *MYO15A* gene are associated with deafness type 3 which is an autosomal recessive disorder. The unconventional myosin XVa protein has an important role in the normal auditory function and other unconventional myosin proteins VI and VIIa mutations also lead to the hearing impairment.^[@bibr14-1179547619871907]^ Previously, several pathogenic mutations related to ARNSHL have been reported in the *MYO15A* gene ([Table 1](#table1-1179547619871907){ref-type="table"}).

###### 

Overview of *MYO15A* mutations in the ARNSHL patients detected in the different populations.

![](10.1177_1179547619871907-table1)

  Domain         cDNA change                       Amino acid change          Origin of family    References
  -------------- --------------------------------- -------------------------- ------------------- ---------------------------------------------------------------------------------------
  N-terminal     c.373_374delCG                    p.R125VfsX101              Ashkenazi, Jewish   Brownstein et al^[@bibr15-1179547619871907]^
  N-terminal     c.535G                            p.E179X                    Japanese            Miyagawa et al^[@bibr16-1179547619871907]^
  N-terminal     c.867C\>G                         p.Y289X                    Turkey              Cengiz et al^[@bibr8-1179547619871907]^
  N-terminal     c.1047C\>A                        p.Y341X                    Russian             Miyagawa et al^[@bibr16-1179547619871907]^
  N-terminal     c.1185dupC                        p.E396fsX431               Pakistan, Japan     Bashir et al,^[@bibr17-1179547619871907]^ Miyagawa et al^[@bibr18-1179547619871907]^
  N-terminal     c.1387A\>G                        p.M463V                    Iran                Fattahi et al^[@bibr12-1179547619871907]^
  N-terminal     c.3020C\>A                        p.P1009H                   China               Yang et al^[@bibr19-1179547619871907]^
  N-terminal     c.3313G\>T                        p.E1105X                   Pakistan            Miyagawa et al,^[@bibr18-1179547619871907]^ Nal et al^[@bibr20-1179547619871907]^
  N-terminal     c.3336delG                        p.G1112fsX1124             Pakistan            Miyagawa et al,^[@bibr18-1179547619871907]^ Nal et al^[@bibr20-1179547619871907]^
  Motor          c.3685C\>T                        p.Q1229X                   Pakistan            Liburd et al^[@bibr21-1179547619871907]^
  Motor          c.3525_3526insA                   p.Q1175fsX1188             China               Li et al^[@bibr22-1179547619871907]^
  Motor          c.4072G\>A                        p.G1358S                   Japanese            Miyagawa et al^[@bibr16-1179547619871907]^
  Motor          c.3756+1G\>T                      p.D1232fsX1241             Pakistan            Liburd et al^[@bibr21-1179547619871907]^
  Motor          c.3758C\>T                        p.T1253I                   India               Nal et al^[@bibr20-1179547619871907]^
  Motor          c.3866+1G\>A                      p.T1253fsX1277             Pakistan            Nal et al^[@bibr20-1179547619871907]^
  Motor          c.4176C\>A                        p.Y1392X                   Pakistan            Nal et al^[@bibr20-1179547619871907]^
  Motor          c.4198G\>A                        p.V1400M                   Turkey              Cengiz et al^[@bibr8-1179547619871907]^
  Motor          c.4240G\>A                        p.E1414K                   Palestinian, Arab   Brownstein et al^[@bibr15-1179547619871907]^
  Motor          c.4273C\>T                        p.Q1425X                   Turkey              Miyagawa et al^[@bibr16-1179547619871907]^
  Motor          c.4351G\>A                        p.D1451N                   India               Nal et al^[@bibr20-1179547619871907]^
  Motor          c.4441T\>C                        p.S1481P                   Turkey              Cengiz et al,^[@bibr8-1179547619871907]^ Diaz-Horta et al^[@bibr23-1179547619871907]^
  Motor          c.4596+1G\>A                                                 Iran                Soveizi et al^[@bibr1-1179547619871907]^
  Motor          c.4652C\>A                        p.A1551D                   Turkey              Miyagawa et al^[@bibr16-1179547619871907]^
  Motor          c.4669A\>G                        p.K1557E                   Pakistan            Nal et al^[@bibr20-1179547619871907]^
  Motor          c.4909_4911delGAG                 p.E1637del                 Iran                Fattahi et al^[@bibr12-1179547619871907]^
  Motor          c.4998G\>A                        p.C1666X                   Tunisia             Belguith et al^[@bibr24-1179547619871907]^
  Motor          c.5117_5118GC\>TT                 p.L1706V                   Pakistan            Miyagawa et al^[@bibr16-1179547619871907]^
  Motor          c.5189T\>C                        p.G1730P                   Pakistan            Nal et al^[@bibr20-1179547619871907]^
  Motor          c.5203C\>T                        p.Arg1735Trp               Moroccan            Salime et al^[@bibr25-1179547619871907]^
  Motor          c.5305A\>G                        p.T1769A                   Iran                Fattahi et al^[@bibr12-1179547619871907]^
  Motor          c.5421delT                        p.F1807LfsX6               Iran                Fattahi et al^[@bibr12-1179547619871907]^
  Motor          c.5492G\>T                        p.G1831V                   Turkey              Kalay et al^[@bibr26-1179547619871907]^
  --             c.5650-1G\>A                      p.A1884fs                  Turkey              Duman et al^[@bibr13-1179547619871907]^
  Motor          c.5810G\>A                        p.R1937H                   Iran                Fattahi et al^[@bibr12-1179547619871907]^
  Motor          c.5808_5814delCCGTGGC             p.R1937TfsX10              Turkey              Cengiz et al^[@bibr8-1179547619871907]^
  IQ Motif       c.5925G\>A                        p.W1975X                   Iran                Fattahi et al^[@bibr12-1179547619871907]^
  IQ Motif       c.5978G\>A                        p.R1993Q                   Japan               Miyagawa et al^[@bibr16-1179547619871907]^
  --             c.6061C\>T                        p.Q2021X                   Pakistan            Nal et al^[@bibr20-1179547619871907]^
  MyTH4          c.6217C\>T                        p.P2073S                   Iran                Shearer et al^[@bibr27-1179547619871907]^
  MyTH4          c.6331A\>T                        p.N2111Y                   India               Wang et al^[@bibr4-1179547619871907]^
  MyTH4          c.6306_6307insG                   p.A2104CfsX18              China               Yang et al^[@bibr19-1179547619871907]^
  MyTH4          c.6337A\>T                        p.I2113F                   Indonesia           Wang et al^[@bibr4-1179547619871907]^
  MyTH4          c.6340G\>A                        p.V2114M                   China               Yang et al^[@bibr19-1179547619871907]^
  MyTH4          c.6371G\>A                        p.R2124Q                   Iran                Shearer et al^[@bibr27-1179547619871907]^
                                                   p.R2146Q                   South Korea         Woo et al^[@bibr28-1179547619871907]^
  MyTH4          c.6487delG                        p.A2153fs                  Japan               Miyagawa et al^[@bibr16-1179547619871907]^
  MyTH4          c.6442T\>A                        p.Trp2148Arg               Iran                Reiisi et al^[@bibr29-1179547619871907]^
  MyTH4          c.6614C\>T                        p.T2205I                   North America       Liburd et al^[@bibr21-1179547619871907]^
  --             c.6731G\>A                        p.G2244E                   Pakistan, Japan     Miyagawa et al,^[@bibr16-1179547619871907]^ Nal et al^[@bibr20-1179547619871907]^
  --             c.6796G\>A                        p.V2266M                   Pakistan, Turkey    Nal et al^[@bibr20-1179547619871907]^
  --             c.6703T\>C                        p.S2235P                   Japan               Miyagawa et al^[@bibr16-1179547619871907]^
  --             c.7395+3G\>C                      --                         Tunisia             Belguith et al^[@bibr24-1179547619871907]^
  SnAPC2 like    c.7801A\>T                        p.K2601X                   India               Wang et al^[@bibr4-1179547619871907]^
  SnAPC2 like    c.7982C\>A                        p.S2661X                   Turkey              Duman et al^[@bibr13-1179547619871907]^
  --             c.8158G\>C                        p.D2720H                   Pakistan            Nal et al^[@bibr20-1179547619871907]^
  --             c.8183G\>A                        p.R2728H                   Jewish, China       Brownstein et al,^[@bibr15-1179547619871907]^ Yang et al^[@bibr19-1179547619871907]^
  --             c.8198A\>C                        p.E2733A                   Japan               Miyagawa et al^[@bibr16-1179547619871907]^
  --             c.8324G\>A                        p.R2775H                   China               Yang et al^[@bibr19-1179547619871907]^
  --             c.8148G\>T                        p.Q2716H                   Pakistan            Liburd et al^[@bibr21-1179547619871907]^
  PH like        c.8467G\>A                        p.D2823N                   Iran                Fattahi et al^[@bibr12-1179547619871907]^
  SH3            c.8767C\>T                        p.R2923X                   China               Woo et al^[@bibr28-1179547619871907]^
  --             c.8968-1G\>C                      --                         Turkey              Kalay et al^[@bibr26-1179547619871907]^
  SH3            c.8821_8822insTG                  p.V2940fsX3034             Pakistan            Nal et al^[@bibr20-1179547619871907]^
  --             c.9229+1G\>A                      --                         Tunisia             Belguith et al^[@bibr24-1179547619871907]^
  MyTH4          c.9413T\>A                        p.L3138Q                   Japan               Yano et al^[@bibr30-1179547619871907]^
  MyTH4          c.9478C\>T                        p.L3160F                   Pakistan            Nal et al^[@bibr20-1179547619871907]^
  MyTH4          c.9517G\>A                        p.G3173R                   Japan               Miyagawa et al^[@bibr16-1179547619871907]^
  **MyTH4**      **c.9611_9612+8del TGGTGAGCAT**   **(p.Leu3204Cysfs\*17)**   **This study**      
  FERM central   c.9958_9961delGACT                p.D3320fs                  Brazil              Lezirovitz et al^[@bibr31-1179547619871907]^
  FERM central   c.9995_10002dupGCCGGCCC           p.S3335AfsX121             Turkey              Cengiz et al^[@bibr8-1179547619871907]^
  FERM central   c.10249_10251delTCC               p.F3417del                 Japan               Miyagawa et al^[@bibr16-1179547619871907]^
  FERM central   c.10263C\>G                       p.I3421M                   Japan               Miyagawa et al^[@bibr16-1179547619871907]^
  FERM central   c.10474C\>T                       p.Q3492X                   Pakistan            Nal et al^[@bibr20-1179547619871907]^
  FERM central   c.10573delA                       p.S3525fs                  Brazil              Lezirovitz et al^[@bibr31-1179547619871907]^

Abbreviations: ARNSHL: autosomal recessive non-syndromic hearing loss; FERM, 4.1 protein, Ezrin, Radixin, and Moesin; MyTH4, Myosin Tail Homology 4; SH3, Src Homology 3.

Myosins are actin-based motor molecules with ATPase activity that drive the movement of actin filaments to facilitate organelle trafficking, cell movement, cytokinesis, signal transduction, and muscle contraction.^[@bibr32-1179547619871907]^ Human myosin XVa includes N-terminal domain, myosin head (motor domain), neck region, and tail domain. The motor domain contains 2 binding sites for adenosine triphosphate and actin. The neck region contains 2 light-chain binding motifs. The tail region contains 2 MyTH4 domains, 2 FERM domains, an SH3 domain, and a C-terminal PDZ-binding ligand domain.^[@bibr12-1179547619871907]^ Myosins highly divergent tails are required for the development and elongation of the stereocilia through the delivery of whirlin to the tips of the stereocilia. Whirlin binds to the SH3-MYTH4-FERM-domains of the myosin XVa protein and regulates actin filament elongation. Hair bundles consist of up to 300 stereocilia and are located at the apex of sensory hair cells in the cochlea and they are responsible for the mechano-electrical transduction of sound waves in the auditory system of human.^[@bibr33-1179547619871907]^ The architecture of the hair bundle and stereocilia length is required in the maintaining of normal hearing function.^[@bibr34-1179547619871907]^

In our patient, a novel homozygous deletion mutation, c.9611_9612+8del TGGTGAGCAT (p.Leu3204Cysfs\*17), was identified in exon 58 of the *MYO15A* gene which creates a shift in the reading frame starting at codon 3204 and predicted to lie in the second MyTH4 domain of myosin XVa. Several mutations in the first and second MyTH4 domains of the myosin XVa protein have been described previously. A study in Japan revealed a homozygous mutation (p.L3138Q) in the MyTH4 domain of the myosin 15a protein in a patient with congenital severe to profound sensorineural hearing loss.^[@bibr30-1179547619871907]^ Also in Pakistan, sequencing of *MYO15A* gene in DFNB3-linked families revealed several pathogenic mutations such as a missense mutations (p.L3160F) in MyTH4 domains of the myosin XVa protein.^[@bibr20-1179547619871907]^ Other similar reports have been summarized in [Table 1](#table1-1179547619871907){ref-type="table"}. The MyTH4 domain in the tail region is found in 1 or 2 copies and has been identified as a conserved domain in the several different unconventional myosins. Even though their specific function is not fully understood, the MyTH4 domains are predicted to be largely alpha-helical which associated with other domains like myosin head, kinesin motor, FERM, PH, SH3, and IQ.^[@bibr35-1179547619871907]^

Conclusions {#section9-1179547619871907}
===========

We have identified a novel variant in the *MYO15A* gene in an Iranian DFNB3 family which affects second MyTH4 domain of the myosin XVa protein. The present result indicates that clinical exome sequencing enabled us to discover rare variants in the highly heterogeneous monogenic diseases like hearing loss. Further analysis of the *MYO15A* gene can facilitate diagnosis of congenital hearing loss in countries with a high level of consanguineous marriage.
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